News

Telix's Illuccix® PSMA-PET Imaging Agent Approved in Germany
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...
TMCnet4d
Lightcast Appoints Industry Veteran Philip Binns as Chairman of the Board
Lightcast, a pioneering life science tools company, today announced the appointment of Philip Binns as chairman of its board of directors, effective May 1, 2025. With this appointment, the Lightcast ...